Literature DB >> 7519232

Manipulation for the control of back pain and curve progression in patients with skeletally mature idiopathic scoliosis: two cases.

G A Tarola1.   

Abstract

OBJECTIVE: This report of two cases illustrates the potential effect of chiropractic manipulative therapy on back pain and curve progression in the at-risk, skeletally mature patient with adolescent idiopathic scoliosis. CLINICAL FEATURE: Two patients suffering from lumbar scoliosis and chronic back pain. Both had scoliosis that had progressed after skeletal maturity. INTERVENTION AND OUTCOME: Diversified type chiropractic manipulative therapy was used palliatively for back pain relief in one case, and routinely 1-2 times per month in the other case. The manipulation was applied manually, with the patients in the prone and side-posture positions. Vertebral levels manipulated were identified as fixated/dysfunctional segments based on static and/or motion palpation. They were generally applied to areas above and/or below the curve apex. When applied at the apex, cavitation was more easily achieved when the direction of thrust was into the concave side. This was also tolerated better by the patient. No attempt was made to "straighten the curve" by thrusting into the convex side. Gentle manual intersegmental mobilization, stretching and muscle massage techniques were also applied. The case treated palliatively had curve progression consistent with the literature over an 8-yr period. The case treated routinely did not. The procedure was effective in both cases for subjective relief of back pain.
CONCLUSIONS: Diversified-type CMT has a favorable effect on acute back pain when used palliatively. The procedure may also have a favorable long term effect of preventing recurrence of back pain and on retarding curve progression when used routinely 1-2 times per month.

Entities:  

Mesh:

Year:  1994        PMID: 7519232

Source DB:  PubMed          Journal:  J Manipulative Physiol Ther        ISSN: 0161-4754            Impact factor:   1.437


  8 in total

1.  Manipulative and rehabilitative therapy as a treatment of idiopathic scoliosis without psychological sequelae: a case report.

Authors:  Jorge H Villafañe; Guillermo B Silva; Andrea Dughera
Journal:  J Chiropr Med       Date:  2012-06

2.  Adults with idiopathic scoliosis improve disability after motor and cognitive rehabilitation: results of a randomised controlled trial.

Authors:  Marco Monticone; Emilia Ambrosini; Daniele Cazzaniga; Barbara Rocca; Lorenzo Motta; Cesare Cerri; Marco Brayda-Bruno; Alessio Lovi
Journal:  Eur Spine J       Date:  2016-03-25       Impact factor: 3.134

3.  Management of a 59-year-old female patient with adult degenerative scoliosis using manipulation under anesthesia.

Authors:  Mark W Morningstar; Megan N Strauchman
Journal:  J Chiropr Med       Date:  2010-06

4.  Adolescent idiopathic scoliosis treatment using pettibon corrective procedures: a case report.

Authors:  Mark W Morningstar; Megan N Strauchman; Greg Gilmour
Journal:  J Chiropr Med       Date:  2004

5.  Scoliosis treatment using spinal manipulation and the Pettibon Weighting System: a summary of 3 atypical presentations.

Authors:  Mark W Morningstar; Timothy Joy
Journal:  Chiropr Osteopat       Date:  2006-01-12

6.  Scoliosis-Specific exercises can reduce the progression of severe curves in adult idiopathic scoliosis: a long-term cohort study.

Authors:  Alessandra Negrini; Maria Gabriella Negrini; Sabrina Donzelli; Michele Romano; Fabio Zaina; Stefano Negrini
Journal:  Scoliosis       Date:  2015-07-11

7.  Adult scoliosis can be reduced through specific SEAS exercises: a case report.

Authors:  Alessandra Negrini; Silvana Parzini; Maria Gabriella Negrini; Michele Romano; Salvatore Atanasio; Fabio Zaina; Stefano Negrini
Journal:  Scoliosis       Date:  2008-12-16

8.  Scoliosis treatment using a combination of manipulative and rehabilitative therapy: a retrospective case series.

Authors:  Mark W Morningstar; Dennis Woggon; Gary Lawrence
Journal:  BMC Musculoskelet Disord       Date:  2004-09-14       Impact factor: 2.362

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.